![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, February 13, 2006 10:02:19 AM
That is because they purchased an investment in Biofrontera. The statement above is misleading, in my opinion. That is why they consider this a "new pharmaceutical pipeline for DNAPrint". If DNAG had purchased a .18% stake in Pfizer, they would be claiming a "new pharmaceutical pipeline" also. It doesn't mean that DNAP will ever work on any of those compounds. Remember, we have had to purchase licensing agreements for the 2 compounds DNAG is trying to develop- I certainly don't think Biofrontera would be any different. So I stand by my earlier statement....:""And unless Biofrontera wants to just share these drugs with an american Penny Stock, then it's nothing more than just an investment." "
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM